Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Gustavo Henrique Marques Sousa, Renan Augusto Gomes, Eliseu Ortega de Oliveira & Gustavo Henrique Goulart Trossini. (2023) Machine learning methods applied for the prediction of biological activities of triple reuptake inhibitors. Journal of Biomolecular Structure and Dynamics 41:20, pages 10277-10286.
Read now
Read now
Xue-Jie Qi, Xiang-Yun Liu, Lei-Meng-Yuan Tang, Pan-Feng Li, Feng Qiu & Ai-Hong Yang. (2020) Anti-depressant effect of curcumin-loaded guanidine-chitosan thermo-sensitive hydrogel by nasal delivery. Pharmaceutical Development and Technology 25:3, pages 316-325.
Read now
Read now
Liana Palermo, Anita MacDonald, Ellie Limback, Louise Robertson, Sarah Howe, Tarekegn Geberhiwot & Cristina Romani. (2020) Emotional health in early-treated adults with phenylketonuria (PKU): Relationship with cognitive abilities and blood phenylalanine. Journal of Clinical and Experimental Neuropsychology 42:2, pages 142-159.
Read now
Read now
Ligen Shi, Jingyi Wang, Shenbin Xu & Yunrong Lu. (2016) Efficacy and tolerability of vilazodone for major depressive disorder: evidence from phase III/IV randomized controlled trials. Drug Design, Development and Therapy 10, pages 3899-3907.
Read now
Read now
Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Ashwin A Patkar, Prakash S Masand & Chi-Un Pae. (2015) Five potential therapeutic agents as antidepressants: a brief review and future directions. Expert Review of Neurotherapeutics 15:9, pages 1015-1029.
Read now
Read now
Parameswara Rao Vuddanda, Amit Mishra, Sanjay Kumar Singh & Sanjay Singh. (2015) Development of polymeric nanoparticles with highly entrapped herbal hydrophilic drug using nanoprecipitation technique: an approach of quality by design. Pharmaceutical Development and Technology 20:5, pages 579-587.
Read now
Read now
Sheng-Min Wang, Changsu Han & Chi-Un Pae. (2015) Criticisms of drugs in early development for the treatment of depression: what can be improved?. Expert Opinion on Investigational Drugs 24:4, pages 445-453.
Read now
Read now
Lokesh Pathak, Yadvendra Agrawal & Ashish Dhir. (2013) Natural polyphenols in the management of major depression. Expert Opinion on Investigational Drugs 22:7, pages 863-880.
Read now
Read now
PETERP. FU, QINGSU XIA, YUEWEI ZHAO, SHUGUANG WANG, HONGTAO YU & HSIU-MEI CHIANG. (2013) Phototoxicity of Herbal Plants and Herbal Products. Journal of Environmental Science and Health, Part C 31:3, pages 213-255.
Read now
Read now
Jolanda Prins, Berend Olivier & S Mechiel Korte. (2011) Triple reuptake inhibitors for treating subtypes of major depressive disorder: the monoamine hypothesis revisited. Expert Opinion on Investigational Drugs 20:8, pages 1107-1130.
Read now
Read now
Articles from other publishers (70)
Lin Liu, Min Liu, Jingya Xiu, Bowen Zhang, Haiyang Hu, Mingxi Qiao, Dawei Chen, Jiulong Zhang & Xiuli Zhao. (2023) Stimuli-responsive nanoparticles delivered by a nasal-brain pathway alleviate depression-like behavior through extensively scavenging ROS. Acta Biomaterialia 171, pages 451-465.
Crossref
Crossref
Ümmühan Kandemir. (2023) Etiopathogenesis of depression and experimental depression models used in preclinical studies. European Journal of Life Sciences 2:2, pages 78-90.
Crossref
Crossref
Syeda Hafiza Afsheen Zafar, Dr. Riffat Farooqui, Ifrah Jawaid, Syeda Afroze, Fahmeed Karim & Dr. Syeda Bushra Zafar. (2023) DOSE-DEPENDENT ANTI-DEPRESSANT EFFECT OF CITRUS PARADISI IN REHABILITATION OF PSYCHOLOGICAL DISORDERS. Pakistan Journal of Rehabilitation 12:1, pages 99-106.
Crossref
Crossref
Shengyang Fu, Huili Chen, Weitao Yang, Xiaohuan Xia, Shu Zhao, Xiaonan Xu, Pu Ai, Qingyuan Cai, Xiangyu Li, Yi Wang, Jie Zhu, Bingbo Zhang & Jialin C. Zheng. (2022) ROS-Targeted Depression Therapy via BSA-Incubated Ceria Nanoclusters. Nano Letters 22:11, pages 4519-4527.
Crossref
Crossref
Chuansheng Yao, Xiaoying Jiang, Xiang‐Yang Ye, Tian Xie & Renren Bai. (2022) Antidepressant Drug Discovery and Development: Mechanism and Drug Design Based on Small Molecules. Advanced Therapeutics 5:5.
Crossref
Crossref
Suresh Paudel, Shuji Wang, Eunae Kim, Dooti Kundu, Xiao Min, Chan Young Shin & Kyeong-Man Kim. (2022) Design, Synthesis, and Functional Evaluation of 1, 5-Disubstituted Tetrazoles as Monoamine Neurotransmitter Reuptake Inhibitors. Biomolecules & Therapeutics 30:2, pages 191-202.
Crossref
Crossref
Sneh Lata, Ashish Dhir, S.V. Kessar, K.N. Singh, S.K. Kulkarni & Pushpinder Singh. (2022) Synthesis and evaluation of variably substituted N-methyl tetrahydroisoquinolines and benzazepines as monoamine reuptake inhibitors. Results in Chemistry 4, pages 100352.
Crossref
Crossref
Yan-Na Ni, Xin-Li Du, Tao Wang, Yuan-Yuan Chen, Xiang-Qing Xu, Song Zhao, Jian-Qi Li & Guan Wang. (2021) Design, Synthesis, and Antidepressant Activity Study of Novel Aryl Piperazines Targeting Both 5-HT1A and Sigma-1 Receptors. Pharmaceutical Fronts 03:04, pages e183-e193.
Crossref
Crossref
Shamprasad Varija Raghu, Avinash Kundadka Kudva, Suresh Rao, Krishna Prasad, Jayesh Mudgal & Manjeshwar Shrinath Baliga. (2021) Dietary agents in mitigating chemotherapy-related cognitive impairment (chemobrain or chemofog): first review addressing the benefits, gaps, challenges and ways forward. Food & Function 12:22, pages 11132-11153.
Crossref
Crossref
Shereen Mohamed Abdel Mawella, Hoda Abdou Hussein, Fadia Zyada, Amal Abdelaal, Doaa R. Ayoub & Ahmed Naguy. (2021) Psychoendocrinology: arginine vasopressin and resilience in patients with major depressive disorder. CNS Spectrums, pages 1-5.
Crossref
Crossref
Shubhadeep Sinha, Sreenivasa Chary, Pankaj Thakur, Leela Talluri, Mohan Reddy, Kamal K Verma, Pradeep Saha, Vijaya B Gupta, Kaja A Ramaiah & Siquafa Z Khanum. (2021) A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder. Cureus.
Crossref
Crossref
Poliane da Silva Calixto, Reinaldo Nóbrega de Almeida, Mirian G.S. Stiebbe Salvadori, Mayara dos Santos Maia, José Maria Barbosa Filho, Marcus Tullius Scotti & Luciana Scotti. (2021) In Silico Study Examining New Phenylpropanoids Targets with Antidepressant Activity. Current Drug Targets 22:5, pages 539-554.
Crossref
Crossref
João Soeiro Teodoro, Ivo F. Machado, Ana Catarina Castela, Anabela Pinto Rolo & Carlos Marques Palmeira. 2021. Nutraceuticals. Nutraceuticals
463
483
.
Peter Illes, Alexei Verkhratsky & Yong Tang. (2020) Pathological ATPergic Signaling in Major Depression and Bipolar Disorder. Frontiers in Molecular Neuroscience 12.
Crossref
Crossref
Damla BİNNETOĞLU, Feyza ARICIOGLU, Halil OZCAN, Ufuk OKKAY & Ahmet HACIMUFTUOGLU. (2019) Antidepressant-Like Effects of Ceftriaxone in Chronic Unpredictable Mild Stress Model in Rats: The Importance of Reuptake Time of Glutamate. Clinical and Experimental Health Sciences 9:4, pages 294-299.
Crossref
Crossref
Touqeer Ahmed, Maheen Nawaz & Waqar Iqbal. 2019. Curcumin for Neurological and Psychiatric Disorders. Curcumin for Neurological and Psychiatric Disorders
129
154
.
Suresh Paudel, Ningning Sun, Daulat Bikram Khadka, Goon Yoon, Kyeong-Man Kim & Seung Hoon Cheon. (2018) Design, synthesis and docking study of 4-arylpiperazine carboxamides as monoamine neurotransmitters reuptake inhibitors. Bioorganic & Medicinal Chemistry 26:14, pages 4127-4135.
Crossref
Crossref
Ranjana Aggarwal & Suresh Kumar. (2018) 5-Aminopyrazole as precursor in design and synthesis of fused pyrazoloazines. Beilstein Journal of Organic Chemistry 14, pages 203-242.
Crossref
Crossref
Xiaohui Zhu, Yangdong Sun, Chenggang Zhang & Haifeng Liu. (2017) Effects of berberine on a rat model of chronic stress and depression via gastrointestinal tract pathology and gastrointestinal flora profile assays. Molecular Medicine Reports 15:5, pages 3161-3171.
Crossref
Crossref
Jaskamal Singh Gill, Sumit Jamwal, Puneet Kumar & Rahul Deshmukh. (2017) Sertraline and venlafaxine improves motor performance and neurobehavioral deficit in quinolinic acid induced Huntington’s like symptoms in rats: Possible neurotransmitters modulation. Pharmacological Reports 69:2, pages 306-313.
Crossref
Crossref
Gao-Ge Sun, Jui-Hu Shih, Shih-Hwa Chiou, Chen-Jee Hong, Shao-Wei Lu & Li-Heng Pao. (2016) Chinese herbal medicines promote hippocampal neuroproliferation, reduce stress hormone levels, inhibit apoptosis, and improve behavior in chronically stressed mice. Journal of Ethnopharmacology 193, pages 159-168.
Crossref
Crossref
Ying Wang, Shu-Ming Gao, Ran Li, Min Zhang, Shan Gao & Chun-Quan Yu. (2016) Antidepressant-like effects of the Radix Bupleuri and Radix Paeoniae Alba drug pair. Neuroscience Letters 633, pages 14-20.
Crossref
Crossref
Fernanda Neutzling Kaufmann, Marta Gazal, Clarissa Ribeiro Bastos, Manuella Pinto Kaster & Gabriele Ghisleni. (2016) Curcumin in depressive disorders: An overview of potential mechanisms, preclinical and clinical findings. European Journal of Pharmacology 784, pages 192-198.
Crossref
Crossref
Suresh Paudel, Srijan Acharya, Kyeong-Man Kim & Seung Hoon Cheon. (2016) Design, synthesis, and biological evaluation of arylpiperazine–benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities. Bioorganic & Medicinal Chemistry 24:9, pages 2137-2145.
Crossref
Crossref
F. Comhaire & A. Mahmoud. (2016) The andrologist's contribution to a better life for ageing men: part 2. Andrologia 48:1, pages 99-110.
Crossref
Crossref
Sheng-Min WangChangsu HanSoo-Jung LeeTae-Youn JunAshwin A PatkarPrakash S MasandChi-Un Pae. (2016) Second Generation Antipsychotics in the Treatment of Major Depressive Disorder: An Update. Chonnam Medical Journal 52:3, pages 159.
Crossref
Crossref
Sheng-Min WangChangsu HanSoo-Jung LeeAshwin A. PatkarPrakash S MasandChi-Un Pae. (2016) Vilazodone for the Treatment of Depression: An Update. Chonnam Medical Journal 52:2, pages 91.
Crossref
Crossref
João S. Teodoro, Filipe V. Duarte, Anabela P. Rolo & Carlos M. Palmeira. 2016. Nutraceuticals. Nutraceuticals
387
400
.
Gen Murakami, Masato Nakamura, Masatoshi Takita, Yasushi Ishida, Takatoshi Ueki & Daiichiro Nakahara. (2015) Brain Rewarding Stimulation Reduces Extracellular Glutamate Through Glial Modulation in Medial Prefrontal Cortex of Rats. Neuropsychopharmacology 40:12, pages 2686-2695.
Crossref
Crossref
Suresh Paudel, Yongkai Cao, Shuohan Guo, Byeongkwan An, Kyeong-Man Kim & Seung Hoon Cheon. (2015) Design and synthesis of 4-benzylpiperidine carboxamides as dual serotonin and norepinephrine reuptake inhibitors. Bioorganic & Medicinal Chemistry 23:19, pages 6418-6426.
Crossref
Crossref
Masayuki Yamashita, Naohiro Taya, Mitsuyoshi Nishitani, Katsuaki Oda, Tetsuji Kawamoto, Eiji Kimura, Yuji Ishichi, Jun Terauchi & Toru Yamano. (2015) Preparation of (S)-4-(1-(3,4-dichlorophenyl)-2-methoxyethyl)piperidine. Tetrahedron: Asymmetry 26:17, pages 935-942.
Crossref
Crossref
Liang Tan, Hongfei Ge, Jun Tang, Chuhua Fu, Wangsheng Duanmu, Yujie Chen, Rong Hu, Jianfeng Sui, Xin Liu & Hua Feng. (2015) Amantadine preserves dopamine level and attenuates depression-like behavior induced by traumatic brain injury in rats. Behavioural Brain Research 279, pages 274-282.
Crossref
Crossref
Minsoo Han, Chiman Song, Nakcheol Jeong & Hoh-Gyu Hahn. (2014) Exploration of 3-Aminoazetidines as Triple Reuptake Inhibitors by Bioisosteric Modification of 3-α-Oxyazetidine. ACS Medicinal Chemistry Letters 5:9, pages 999-1004.
Crossref
Crossref
Q.-S. Wang, J.-S. Tian, Y.-L. Cui & S. Gao. (2014) Genipin is active via modulating monoaminergic transmission and levels of brain-derived neurotrophic factor (BDNF) in rat model of depression. Neuroscience 275, pages 365-373.
Crossref
Crossref
Jun Yun, Minsoo Han, Chiman Song, Seung Hoon Cheon, Kihang Choi & Hoh-Gyu Hahn. (2014) Synthesis and biological evaluation of 3-phenethylazetidine derivatives as triple reuptake inhibitors. Bioorganic & Medicinal Chemistry Letters 24:15, pages 3234-3237.
Crossref
Crossref
Wei Ang, Gong Chen, Li Xiong, Ying Chang, Weiyi Pi, Yuanyuan Liu, Chunlong Li, Jiajia Zheng, Liangxue Zhou, Bo Yang, Yong Deng, Shengyong Yang, Youfu Luo & Yuquan Wei. (2014) Synthesis and biological evaluation of novel naphthalene compounds as potential antidepressant agents. European Journal of Medicinal Chemistry 82, pages 263-273.
Crossref
Crossref
Jayesh Sanmukhani, Vimal Satodia, Jaladhi Trivedi, Tejas Patel, Deepak Tiwari, Bharat Panchal, Ajay Goel & Chandra Bhanu Tripathi. (2014) Efficacy and Safety of Curcumin in Major Depressive Disorder: A Randomized Controlled Trial. Phytotherapy Research 28:4, pages 579-585.
Crossref
Crossref
Min Cui, Qiang Li, Min Zhang, Ya-Juan Zhao, Fei Huang & Yong-Jin Chen. (2014) Long-term curcumin treatment antagonizes masseter muscle alterations induced by chronic unpredictable mild stress in rats. Archives of Oral Biology 59:3, pages 258-267.
Crossref
Crossref
Pei-Yan Zhan, Cai-Xia Peng & Lin-Hong Zhang. (2014) Berberine rescues d-galactose-induced synaptic/memory impairment by regulating the levels of Arc. Pharmacology Biochemistry and Behavior 117, pages 47-51.
Crossref
Crossref
Parameswara Rao Vuddanda, Vijayakumar Mahalingam Rajamanickam, Madhu Yaspal & Sanjay Singh. (2014) Investigations on Agglomeration and Haemocompatibility of Vitamin E TPGS Surface Modified Berberine Chloride Nanoparticles. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Esther Jortzik, Lihui Wang, Jipeng Ma & Katja Becker. 2014. Flavins and Flavoproteins. Flavins and Flavoproteins
113
157
.
Gian Marco Leggio, Salvatore Salomone, Claudio Bucolo, Chiara Platania, Vincenzo Micale, Filippo Caraci & Filippo Drago. (2013) Dopamine D3 receptor as a new pharmacological target for the treatment of depression. European Journal of Pharmacology 719:1-3, pages 25-33.
Crossref
Crossref
Xing Fang, Lin Guo, Jia Jia, Guo-zhang Jin, Bin Zhao, Yong-yong Zheng, Jian-qi Li, Ao Zhang & Xue-chu Zhen. (2013) SKF83959 is a novel triple reuptake inhibitor that elicits anti-depressant activity. Acta Pharmacologica Sinica 34:9, pages 1149-1155.
Crossref
Crossref
Yuji Ishichi, Eiji Kimura, Eiji Honda, Masato Yoshikawa, Takashi Nakahata, Yasuko Terao, Atsuko Suzuki, Takayuki Kawai, Yuuichi Arakawa, Hiroyuki Ohta, Naoyuki Kanzaki, Hideyuki Nakagawa & Jun Terauchi. (2013) Novel triple reuptake inhibitors with low risk of CAD associated liabilities: Design, synthesis and biological activities of 4-[(1S)-1-(3,4-dichlorophenyl)-2-methoxyethyl]piperidine and related compounds. Bioorganic & Medicinal Chemistry 21:15, pages 4600-4613.
Crossref
Crossref
Shan Gao, Yuan-Lu Cui, Chun-Quan Yu, Qiang-Song Wang & Ye Zhang. (2013) Tetrandrine exerts antidepressant-like effects in animal models: Role of brain-derived neurotrophic factor. Behavioural Brain Research 238, pages 79-85.
Crossref
Crossref
HONGYING ZHANG, BAOJUN LIU, JINFENG WU, CHANGQING XU, JIANG TAO, XIAOHONG DUAN, YUXUE CAO & JINGCHENG DONG. (2012) Icariin inhibits corticosterone-induced apoptosis in hypothalamic neurons via the PI3-K/Akt signaling pathway. Molecular Medicine Reports 6:5, pages 967-972.
Crossref
Crossref
Younghue Han, Minsoo Han, Dongyun Shin, Chiman Song & Hoh-Gyu Hahn. (2012) Exploration of Novel 3-Substituted Azetidine Derivatives As Triple Reuptake Inhibitors. Journal of Medicinal Chemistry 55:18, pages 8188-8192.
Crossref
Crossref
Anna Maria Capelli & Fabrizio Micheli. (2012) Triple monoamine uptake inhibitors. Pharmaceutical Patent Analyst 1:4, pages 469-481.
Crossref
Crossref
Min-Soo Han, Young-Hue Han, Chi-Man Song & Hoh-Gyu Hahn. (2012) The Design and Synthesis of 1,4-Substituted Piperazine Derivatives as Triple Reuptake Inhibitors. Bulletin of the Korean Chemical Society 33:8, pages 2597-2602.
Crossref
Crossref
Linda Brand, Jurgens van Zyl, Estella L. Minnaar, Francois Viljoen, Jan L. du Preez, Gregers Wegener & Brian H. Harvey. (2014) Corticolimbic changes in acetylcholine and cyclic guanosine monophosphate in the Flinders Sensitive Line rat: a genetic model of depression. Acta Neuropsychiatrica 24:4, pages 215-225.
Crossref
Crossref
Yong-Yong Zheng, Lin Guo, Xue-Chu Zhen & Jian-Qi Li. (2012) Synthesis and antidepressant activity of arylalkanol-piperidine derivatives as triple reuptake inhibitors. European Journal of Medicinal Chemistry 54, pages 123-136.
Crossref
Crossref
Chandrashekaran Girish, Vishnu Raj, Jayasree Arya & Sadasivam Balakrishnan. (2012) Evidence for the involvement of the monoaminergic system, but not the opioid system in the antidepressant-like activity of ellagic acid in mice. European Journal of Pharmacology 682:1-3, pages 118-125.
Crossref
Crossref
Matthew J. Robson, Meenal Elliott, Michael J. Seminerio & Rae R. Matsumoto. (2012) Evaluation of sigma (σ) receptors in the antidepressant-like effects of ketamine in vitro and in vivo. European Neuropsychopharmacology 22:4, pages 308-317.
Crossref
Crossref
Z. Shi, X.H. Ma, C. Qin, J. Jia, Y.Y. Jiang, C.Y. Tan & Y.Z. Chen. (2012) Combinatorial support vector machines approach for virtual screening of selective multi-target serotonin reuptake inhibitors from large compound libraries. Journal of Molecular Graphics and Modelling 32, pages 49-66.
Crossref
Crossref
Limei Hui, Yuzhuo Zhang, Junhua Wang, Aaron Cook, Hui Ye, Michael P. Nusbaum & Lingjun Li. (2011) Discovery and Functional Study of a Novel Crustacean Tachykinin Neuropeptide. ACS Chemical Neuroscience 2:12, pages 711-722.
Crossref
Crossref
Hyung-Mun Yun & Hyewhon Rhim. (2011) 5-HT6 receptor ligands, EMD386088 and SB258585, differentially regulate 5-HT6 receptor-independent events. Toxicology in Vitro 25:8, pages 2035-2040.
Crossref
Crossref
Thomas C. Baghai, Pierre Blier, David S. Baldwin, Michael Bauer, Guy M. Goodwin, Kostas N. Fountoulakis, Siegfried Kasper, Brian E. Leonard, Ulrik F. Malt, Dan Stein, Marcio Versiani & Hans-Jürgen Möller. (2011) General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry. European Archives of Psychiatry and Clinical Neuroscience 261:S3, pages 207-245.
Crossref
Crossref
Ashish Dhir, Sneh Malik, S.V. Kessar, K.N. Singh & S.K. Kulkarni. (2011) Evaluation of antidepressant activity of 1-(7-methoxy-2-methyl-1,2,3,4-tetrahydro-isoquinolin-4-YL)-cyclohexanol, a ?-substituted phenylethylamine in mice. European Neuropsychopharmacology 21:9, pages 705-714.
Crossref
Crossref
Kevin N Hascup, Erin R Hascup, Michelle L Stephens, Paul EA Glaser, Takashi Yoshitake, Aleksander A Mathé, Greg A Gerhardt & Jan Kehr. (2011) Resting Glutamate Levels and Rapid Glutamate Transients in the Prefrontal Cortex of the Flinders Sensitive Line Rat: A Genetic Rodent Model of Depression. Neuropsychopharmacology 36:8, pages 1769-1777.
Crossref
Crossref
Fabrizio Micheli, Paolo Cavanni, Michela Bettati, Giorgio Bonanomi, Romano Di Fabio, Elettra Fazzolari, Carla Marchioro, Maja Roscic, Luca Tarsi, Filippo Visentini, Laura Zonzini & Angela Worby. (2011) 1-Heteroaryl-6-(3,4-dichlorophenyl)-3-azabicyclo[4.1.0]heptane: Further insights into a class of triple re-uptake inhibitors. Bioorganic & Medicinal Chemistry 19:11, pages 3451-3461.
Crossref
Crossref
Dave J. Hayes & Andrew J. Greenshaw. (2011) 5-HT receptors and reward-related behaviour: A review. Neuroscience & Biobehavioral Reviews 35:6, pages 1419-1449.
Crossref
Crossref
Piotr Gałecki, Michael Maes, Antoni Florkowski, Andrzej Lewiński, Elżbieta Gałecka, Małgorzata Bieńkiewicz & Janusz Szemraj. (2011) Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder. Journal of Affective Disorders 129:1-3, pages 175-182.
Crossref
Crossref
Li-Tao Yi, He-Li Xu, Jing Feng, Xia Zhan, Li-Pan Zhou & Cun-Cang Cui. (2011) Involvement of monoaminergic systems in the antidepressant-like effect of nobiletin. Physiology & Behavior 102:1, pages 1-6.
Crossref
Crossref
Zhicheng Lin, Juan J. Canales, Thröstur Björgvinsson, Morgane Thomsen, Hong Qu, Qing-Rong Liu, Gonzalo E. Torres & S. Barak Caine. 2011. The Brain as a Drug Target. The Brain as a Drug Target
1
46
.
Fabrizio Micheli, Paolo Cavanni, Daniele Andreotti, Roberto Arban, Roberto Benedetti, Barbara Bertani, Michela Bettati, Letizia Bettelini, Giorgio Bonanomi, Simone Braggio, Renzo Carletti, Anna Checchia, Mauro Corsi, Elettra Fazzolari, Stefano Fontana, Carla Marchioro, Emilio Merlo-Pich, Michele Negri, Beatrice Oliosi, Emiliangelo Ratti, Kevin D. ReadMaja Roscic, Ilaria Sartori, Simone Spada, Giovanna Tedesco, Luca Tarsi, Silvia Terreni, Filippo Visentini, Alessandro Zocchi, Laura Zonzini & Romano Di Fabio. (2010) 6-(3,4-Dichlorophenyl)-1-[(Methyloxy)methyl]-3-azabicyclo[4.1.0]heptane: A New Potent and Selective Triple Reuptake Inhibitor. Journal of Medicinal Chemistry 53:13, pages 4989-5001.
Crossref
Crossref
Yasuhisa Fukuo, Taro Kishi, Reiji Yoshimura, Tsuyoshi Kitajima, Tomo Okochi, Yoshio Yamanouchi, Yoko Kinoshita, Kunihiro Kawashima, Hiroshi Naitoh, Wakako Umene-Nakano, Toshiya Inada, Hiroshi Kunugi, Tadafumi Kato, Takeo Yoshikawa, Hiroshi Ujike, Jun Nakamura, Norio Ozaki & Nakao Iwata. (2010) Serotonin 6 receptor gene and mood disorders: Case–control study and meta-analysis. Neuroscience Research 67:3, pages 250-255.
Crossref
Crossref
Fabrizio Micheli, Paolo Cavanni, Roberto Arban, Roberto Benedetti, Barbara Bertani, Michela Bettati, Letizia Bettelini, Giorgio Bonanomi, Simone Braggio, Anna Checchia, Silvia Davalli, Romano Di Fabio, Elettra Fazzolari, Stefano Fontana, Carla Marchioro, Doug Minick, Michele Negri, Beatrice Oliosi, Kevin D. ReadIlaria Sartori, Giovanna Tedesco, Luca Tarsi, Silvia Terreni, Filippo Visentini, Alessandro Zocchi & Laura Zonzini. (2010) 1-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes and 6-(Aryl)-6-[alkoxyalkyl]-3-azabicyclo[3.1.0]hexanes: A New Series of Potent and Selective Triple Reuptake Inhibitors. Journal of Medicinal Chemistry 53:6, pages 2534-2551.
Crossref
Crossref
Michela Bettati, Paolo Cavanni, Romano Di Fabio, Beatrice Oliosi, Ornella Perini, Gunther Scheid, Giovanna Tedesco, Laura Zonzini & Fabrizio Micheli. (2010) Oxa-azaspiro Derivatives: a Novel Class of Triple Re-uptake Inhibitors. ChemMedChem 5:3, pages 361-366.
Crossref
Crossref
Massimo Gennarelli & Annamaria Cattaneo. 2010. Pharmacology of 5-HT6 receptors - Part 1. Pharmacology of 5-HT6 receptors - Part 1
129
151
.
Jeffrey M. Witkin & Xia Li. 2009. Contemporary Aspects of Biomedical Research - Drug Discovery. Contemporary Aspects of Biomedical Research - Drug Discovery
347
379
.